Radiotherapy Monitoring Devices Market Size, Share, and Trends 2026 to 2035

Radiotherapy Monitoring Devices Market (By Device: Imaging devices, Sensors and detectors, Treatment planning systems; By End-User: Hospitals, Diagnostic centers, Cancer research institutes; By Component: Hardware, Software) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035

Last Updated : 06 Mar 2026  |  Report Code : 8026  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Radiotherapy Monitoring Devices Market 

5.1. COVID-19 Landscape: Radiotherapy Monitoring Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Radiotherapy Monitoring Devices Market, By Device

8.1. Radiotherapy Monitoring Devices Market Revenue and Volume, by Device

8.1.1 Imaging devices

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Sensors and detectors

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Treatment planning systems

8.1.3.1. Market Revenue and Volume Forecast

Chapter 9. Global Radiotherapy Monitoring Devices Market, By End-User

9.1. Radiotherapy Monitoring Devices Market Revenue and Volume, by End-User

9.1.1. Hospitals

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Diagnostic centers

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Cancer research institutes

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Radiotherapy Monitoring Devices Market, By Component

10.1. Radiotherapy Monitoring Devices Market Revenue and Volume, by Component

10.1.1. Hardware

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Software

10.1.2.1. Market Revenue and Volume Forecast

Chapter 11. Global Radiotherapy Monitoring Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Device

11.1.2. Market Revenue and Volume Forecast, by End-User

11.1.3. Market Revenue and Volume Forecast, by Component

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Device

11.1.4.2. Market Revenue and Volume Forecast, by End-User

11.1.4.3. Market Revenue and Volume Forecast, by Component

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Device

11.1.5.2. Market Revenue and Volume Forecast, by End-User

11.1.5.3. Market Revenue and Volume Forecast, by Component

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Device

11.2.2. Market Revenue and Volume Forecast, by End-User

11.2.3. Market Revenue and Volume Forecast, by Component

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Device

11.2.4.2. Market Revenue and Volume Forecast, by End-User

11.2.4.3. Market Revenue and Volume Forecast, by Component

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Device

11.2.5.2. Market Revenue and Volume Forecast, by End-User

11.2.5.3. Market Revenue and Volume Forecast, by Component

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Device

11.2.6.2. Market Revenue and Volume Forecast, by End-User

11.2.6.3. Market Revenue and Volume Forecast, by Component

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Device

11.2.7.2. Market Revenue and Volume Forecast, by End-User

11.2.7.3. Market Revenue and Volume Forecast, by Component

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Device

11.3.2. Market Revenue and Volume Forecast, by End-User

11.3.3. Market Revenue and Volume Forecast, by Component

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Device

11.3.4.2. Market Revenue and Volume Forecast, by End-User

11.3.4.3. Market Revenue and Volume Forecast, by Component

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Device

11.3.5.2. Market Revenue and Volume Forecast, by End-User

11.3.5.3. Market Revenue and Volume Forecast, by Component

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Device

11.3.6.2. Market Revenue and Volume Forecast, by End-User

11.3.6.3. Market Revenue and Volume Forecast, by Component

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Device

11.3.7.2. Market Revenue and Volume Forecast, by End-User

11.3.7.3. Market Revenue and Volume Forecast, by Component

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Device

11.4.2. Market Revenue and Volume Forecast, by End-User

11.4.3. Market Revenue and Volume Forecast, by Component

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Device

11.4.4.2. Market Revenue and Volume Forecast, by End-User

11.4.4.3. Market Revenue and Volume Forecast, by Component

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Device

11.4.5.2. Market Revenue and Volume Forecast, by End-User

11.4.5.3. Market Revenue and Volume Forecast, by Component

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Device

11.4.6.2. Market Revenue and Volume Forecast, by End-User

11.4.6.3. Market Revenue and Volume Forecast, by Component

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Device

11.4.7.2. Market Revenue and Volume Forecast, by End-User

11.4.7.3. Market Revenue and Volume Forecast, by Component

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Device

11.5.2. Market Revenue and Volume Forecast, by End-User

11.5.3. Market Revenue and Volume Forecast, by Component

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Device

11.5.4.2. Market Revenue and Volume Forecast, by End-User

11.5.4.3. Market Revenue and Volume Forecast, by Component

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Device

11.5.5.2. Market Revenue and Volume Forecast, by End-User

11.5.5.3. Market Revenue and Volume Forecast, by Component

Chapter 12. Company Profiles

12.1. Elekta AB

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Fluke Corp.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. C RAD AB

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Best Medical International Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Brainlab AG

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Accuray Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. GE Healthcare Technologies

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. LAP GmbH

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Koninklijke Philips NV

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Modus Medical Devices Inc.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The radiotherapy monitoring devices market size is expected to increase from USD 1.29 billion in 2025 to USD 2.48 billion by 2035.

Answer : The radiotherapy monitoring devices market is expected to grow at a compound annual growth rate (CAGR) of around 6.74% from 2026 to 2035.

Answer : The major players in the radiotherapy monitoring devices market include Accuray Inc., Brainlab AG, Best Medical International Inc., C RAD AB, Fluke Corp., Elekta AB, GE Healthcare Technologies, LAP GmbH, Koninklijke Philips NV, Modus Medical Devices Inc., RaySearch Laboratories, Orfit Industries NV, and ScandiDos AB

Answer : The driving factors of the radiotherapy monitoring devices market are rapidly growing due to the rising cancer prevalence, technological innovations in radiation delivery, and the adoption of AI in radiotherapy, enabling more accurate tumor targeting and improved treatment planning drive demand for intelligent, connected monitoring devices.

Answer : North America region will lead the global radiotherapy monitoring devices market during the forecast period 2026 to 2035.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client